Oncology Institute Inc (NASDAQ:TOI) has a beta value of 0.48 and has seen 1.52 million shares traded in the recent trading session. The TOI stock price is -1566.67% off its 52-week high price of $2.50 and 13.33% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.77 million shares traded. The 3-month trading volume is 824.63K shares.
The consensus among analysts is that Oncology Institute Inc (TOI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oncology Institute Inc (NASDAQ:TOI) trade information
Sporting -4.94% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TOI stock price touched $0.15 or saw a rise of 39.98%. Year-to-date, Oncology Institute Inc shares have moved -92.82%, while the 5-day performance has seen it change -12.86%. Over the past 30 days, the shares of Oncology Institute Inc (NASDAQ:TOI) have changed -55.00%. Short interest in the company has seen 0.25 million shares shorted with days to cover at 3.38.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 98.12% from the levels at last check today. The projected low price target is $6.0 while the price target rests at a high of $10.0. In that case, then, we find that the latest price level in today’s session is -6566.67% off the targeted high while a plunge would see the stock gain -3900.0% from the levels at last check today.
Oncology Institute Inc (TOI) estimates and forecasts
The company’s shares have lost -69.44% over the past 6 months, compared to 4.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -879.48% over the past 5 years.
TOI Dividends
Oncology Institute Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Insiders own 19.56% of the company shares, while shares held by institutions stand at 47.59% with a share float percentage of 59.16%. Investors are also buoyed by the number of investors in a company, with Oncology Institute Inc having a total of 45.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 4.75 million shares worth more than $2.19 million. As of 2024-06-30, FMR LLC held 6.4005% of shares outstanding.
The other major institutional holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with the holding of over 3.36 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.55 million and represent 4.5263% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 1.69% shares in the company for having 1.27 shares of worth $0.19 million while later fund manager owns 422.98 shares of worth $63997.0 as of Jun 30, 2024, which makes it owner of about 0.56% of company’s outstanding stock.
